Preliminary study on general safe medication regularity of Chinese patent orthopedic medicines based on adverse reaction/event literature analysis.
- Author:
Yu-guang WANG
;
Xin-yuan SHI
;
Rui JIN
;
Hong-yan LI
;
Xiang-wen KONG
;
Yan-jiang QIAO
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Bone Diseases;
drug therapy;
Drug-Related Side Effects and Adverse Reactions;
etiology;
Drugs, Chinese Herbal;
adverse effects;
therapeutic use;
Female;
Humans;
Male;
Middle Aged;
Nonprescription Drugs;
Orthopedics;
legislation & jurisprudence;
Young Adult
- From:
China Journal of Chinese Materia Medica
2015;40(6):1192-1197
- CountryChina
- Language:Chinese
-
Abstract:
Chinese patent orthopedic medicines feature complex components, mainly including desperate and toxic herbal pieces, narrow safety window, more clinical contraindications and frequent adverse drug reaction/events (ADR/ADE). To study the general safe medication regularity of Chinese patent orthopedic medicines, define key points in the medication education and ensure rational clinical medication, the authors took 80 types of commonly used Chinese patent orthopedic medicines as the study objects, collect 237 cases from 164 ADR/ADE documents through a system retrieval strategy, make a multidimensional literature analysis to determine the common risk factors for safe and rational medication of Chinese patent orthopedic medicines and establish an ADR/ADE prevention regularity. First, in the aspect of clinical symptoms, skin allergy is the most common ADR/ADE and closely related to the toxic ingredients, particularly accumulated liver or kidney damage caused by some drugs. Second, there are three time nodes in the ADR/ADE occurrence; The ADR/ADE occurred in 30 minutes is closely related to the idiosyncrasy; the ADR/ADE occurred between several months and half a year is related to the drug-induced liver and kidney damages; The most common ADR/ADE was observed within 7 days and predictable according to the pharmacological actions; Third, toxicity is an important factor in the occurrence of ADR/ADE of Chinese patent orthopedic medicines. Fourth, emphasis shall be given to the special medication factors, such as the combination with western medicines and Chinese herbal decoctions, overdose and long-course medication and self-medical therapy. In conclusion, the general ADR/ADE prevention regularity for Chinese patent orthopedic medicines was summarized to provide supports for clinicians in safe and rational medication and give the guidance for pharmacist in medication education.
